Ticker

I rate iShares US Medical Devices ETF a buy, as its recent selloff offers an attractive entry into industry-leading medical device innovators. IHI's top holdings—Abbott Laboratories, Intuitive Surgical, and Boston Scientific—drive growth through strong fundamentals, product innovation, and exposure to secular healthcare trends. Despite higher fees (0.38%) and volatility, IHI's concentrated exposure to medical…

Market volatility from Iran tensions has created dip-buying chances. Here are 5 ETFs across tech, semis, dividends, healthcare and financials.

Launched on May 1, 2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.

Ameritas Advisory Services LLC trimmed its holdings in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI) by 93.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,069 shares of the company's stock after selling 28,474 shares during

Over the past three years, healthcare has been among the worst-performing sectors. 2026's market rotation away from tech is bringing new life to more defensive areas of the market.